LoginRegister
    JnJ hip implants: CDSCO orders compensation of over Rs 2 crore for 2 more patientsJnJ hip implants: CDSCO orders compensation of over Rs 2 crore for 2 more patients
    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of USSanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US
    AstraZeneca ties up with Transgene to develop viral immunotherapiesAstraZeneca ties up with Transgene to develop viral immunotherapies
    Novartis division strikes deal with Eir Genix to market biosimilar of HerceptinNovartis division strikes deal with Eir Genix to market biosimilar of Herceptin
    Pfizer Q1 profit up 9 percent on higher drug sales, lower costsPfizer Q1 profit up 9 percent on higher drug sales, lower costs
    GSK expects shingles drug sales to exceed $1.3 billionGSK expects shingles drug sales to exceed $1.3 billion
    Zydus Cadila gets USFDA nod to market 2 generic drugsZydus Cadila gets USFDA nod to market 2 generic drugs
    RAID: CDSCO seizes 2350 kg drugs including Erythromycin, Vitamon D, Folic Acid worth over Rs 1.5 crores in ChennaiRAID: CDSCO seizes 2350 kg drugs including Erythromycin, Vitamon D, Folic Acid worth over Rs 1.5...
    Vaccine and blood thinner help drive Pfizer to quarterly earnings beatVaccine and blood thinner help drive Pfizer to quarterly earnings beat
    USFDA declines to approve NabrivaUSFDA declines to approve Nabriva's antibiotic Contepo for urinary tract infections
    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, RemozenGlenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen
    CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in IndiaCDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X